Search details
1.
Long-term survival and functional outcomes of laparoscopic surgery for clinical stage I ultra-low rectal cancers located within 5 cm of the anal verge: A prospective phase II trial (Ultimate trial).
Ann Surg
; 2024 Apr 01.
Article
in English
| MEDLINE | ID: mdl-38557445
2.
How Does Omitting Additional Surgery After Local Excision Affect the Prognostic Outcome of Patients With High-risk T1 Colorectal Cancer?
Ann Surg
; 279(2): 290-296, 2024 Feb 01.
Article
in English
| MEDLINE | ID: mdl-37669045
3.
Long-term outcomes of additional surgery after endoscopic resection versus primary surgery for T1 colorectal cancer.
Am J Gastroenterol
; 2024 Jun 12.
Article
in English
| MEDLINE | ID: mdl-38864517
4.
Treatment Decision for Locally Resected T1 Colorectal Carcinoma-Verification of the Japanese Guideline Criteria for Additional Surgery Based on Long-Term Clinical Outcomes.
Am J Gastroenterol
; 2024 Mar 29.
Article
in English
| MEDLINE | ID: mdl-38345215
5.
Short- and long-term outcomes of surgical treatment for inguinal lymph node metastasis in rectal and anal canal adenocarcinoma.
Colorectal Dis
; 2024 Jun 16.
Article
in English
| MEDLINE | ID: mdl-38881213
6.
Final analyses of the prospective controlled trial on the efficacy of uracil and tegafur/leucovorin as an adjuvant treatment for stage II colon cancer with risk factors for recurrence using propensity score-based methods (JFMC46-1201).
Int J Clin Oncol
; 2024 Jun 04.
Article
in English
| MEDLINE | ID: mdl-38833114
7.
Tyrosine kinase alterations in colorectal cancer with emphasis on the distinct clinicopathological characteristics.
Histopathology
; 83(5): 733-742, 2023 Nov.
Article
in English
| MEDLINE | ID: mdl-37503542
8.
Nomogram as a novel predictive tool for lymph node metastasis in T1 colorectal cancer treated with endoscopic resection: a nationwide, multicenter study.
Gastrointest Endosc
; 97(6): 1119-1128.e5, 2023 06.
Article
in English
| MEDLINE | ID: mdl-36669574
9.
The methylation level of a single cancer risk marker gene reflects methylation burden in gastric mucosa.
Gastric Cancer
; 26(5): 667-676, 2023 09.
Article
in English
| MEDLINE | ID: mdl-37219707
10.
Prognostic factors in patients with high-risk stage II colon cancer after curative resection: a post hoc analysis of the JFMC46-1201 trial.
Int J Colorectal Dis
; 38(1): 260, 2023 Oct 31.
Article
in English
| MEDLINE | ID: mdl-37903983
11.
Analysis of Circulating DNA to Assess Prognoses for Metastatic Colorectal Cancer Patients Treated with Regorafenib Dose-Escalation Therapy: A Retrospective, Exploratory Analysis of the RECC Trial.
Digestion
; 104(3): 233-242, 2023.
Article
in English
| MEDLINE | ID: mdl-36646047
12.
Risk factors for small-bowel obstruction after colectomy for colorectal cancer: a retrospective study.
Surg Today
; 53(9): 1038-1046, 2023 Sep.
Article
in English
| MEDLINE | ID: mdl-36949236
13.
Examination of colorectal cancer cases with metal allergy.
Surg Today
; 53(7): 753-761, 2023 Jul.
Article
in English
| MEDLINE | ID: mdl-36757618
14.
[Development for the Simultaneous Analytical Method of Furan and Alkyl Furans in Processed Foods].
Shokuhin Eiseigaku Zasshi
; 64(1): 29-33, 2023.
Article
in Japanese
| MEDLINE | ID: mdl-36858589
15.
[A Case of Cecum Cancer with Lymph Node Metastasis and Invasion in the Superior Mesenteric Vein Treated with Combined SMV Resection and Reconstruction].
Gan To Kagaku Ryoho
; 50(4): 553-555, 2023 Apr.
Article
in Japanese
| MEDLINE | ID: mdl-37066485
16.
Prospective observational study of the efficacy of oral uracil and tegafur plus leucovorin for stage II colon cancer with risk factors for recurrence using propensity score matching (JFMC46-1201).
BMC Cancer
; 22(1): 170, 2022 Feb 15.
Article
in English
| MEDLINE | ID: mdl-35168560
17.
Management of inguinal lymph node metastases from rectal and anal canal adenocarcinoma.
Colorectal Dis
; 24(10): 1150-1163, 2022 10.
Article
in English
| MEDLINE | ID: mdl-35505622
18.
Efficacy and safety of regorafenib dose-escalation therapy for Japanese patients with refractory metastatic colorectal cancer (RECC study).
Int J Clin Oncol
; 27(8): 1300-1308, 2022 Aug.
Article
in English
| MEDLINE | ID: mdl-35635652
19.
Biweekly TAS-102 and bevacizumab as third-line chemotherapy for advanced or recurrent colorectal cancer: a phase II, multicenter, clinical trial (TAS-CC4 study).
Int J Clin Oncol
; 27(12): 1859-1866, 2022 Dec.
Article
in English
| MEDLINE | ID: mdl-36201089
20.
[A Case of Recurrence in the Abdominal Wall and Perineal Region of Rectal Cancer Successfully Treated with Minimally Invasive Surgery and Radiation Therapy].
Gan To Kagaku Ryoho
; 49(13): 1420-1422, 2022 Dec.
Article
in Japanese
| MEDLINE | ID: mdl-36733088